Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study

The 4th International Symposium on Alzheimer's Disease and Related Disorders in the Middle East, October 26–28, 2007, Athens, Greece

(2010) Changiz Geula et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Bortezomib With or Without Dexamethasone in Primary Systemic (Light Chain) Amyloidosis

(2010) Efstathios Kastritis et al.   JOURNAL OF CLINICAL ONCOLOGY

Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study

(2009) D. E. Reece et al.   BLOOD

How I treat amyloidosis

(2009) R. L. Comenzo   BLOOD

Current treatment of AL amyloidosis

(2009) G. Palladini et al.   HAEMATOLOGICA

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

(2009) S Vincent Rajkumar et al.   LANCET ONCOLOGY